Increase in use of electronic prescriptions during coronavirus
More than 85% of primary care prescriptions in England are now processed electronically, after a rise in use of the service during the coronavirus (COVID-19) pandemic.
Latest data, covering April 2020, shows that 86% of prescriptions dispensed within primary care in England were processed using the Electronic Prescription Service (EPS).
That is an increase of more than 10 percentage points since February, when the usage was 73%. In April 2019, usage was 68%.
EPS saves the NHS time and money by reducing the amount of paper processing required by GPs, pharmacists, non-medical prescribers and the NHS Business Services Authority.
It has benefitted patients and clinicians during the coronavirus crisis as processing prescriptions electronically reduces the need for face-to-face contact and unnecessary journeys.
During April this year, use of EPS was expanded into GP Access/virtual hubs, walk-in centres and out of hours settings. This expansion and focus on increasing the use of EPS in urgent care has contributed to increase in prescriptions processed using this system.
In EPS, patients can choose or ‘nominate’ a pharmacy and/or Dispensing Appliance Contractor (DAC) for their prescriptions to be sent to electronically.
One-off nomination is now available in many GP practices and other care settings, allowing prescriptions to be sent to an alternative pharmacy without affecting patients’ existing nominations and avoiding the need for paper.
Sam Robinson, Associate Director of Live Services at NHS Digital, yesterday said:
“Sending prescriptions electronically not only increases efficiency and saves the NHS money, it also helps patients and staff practice social distancing by reducing contacts.
“We are proud that EPS is supporting clinicians and prescribers to care for patients during this challenging time.”
Latest figures show that 54% of GP practices are now using Phase 4 of EPS, which allows the service to be used for patients without a nominated pharmacy and prescriptions to be downloaded using the unique prescription ID. Roll-out of EPS Phase 4 began last November.
GPs have also been encouraged to transfer patients to electronic repeat dispensing (eRD). This means that for patients with regular medication, a batch of prescriptions can be issued which will be available, at set intervals, to the patient’s nominated pharmacy. Medication can therefore be prepared in advance by the pharmacy, without patients having to request it from their practice each time. Before dispensing the medication, the pharmacist will confirm it is still safe, appropriate for the patient and that they still require a supply, and answer any questions they may have.
The need for patients to individually consent to being moved to eRD has temporarily been suspended to enable increased use during the coronavirus response. Practices in England may transfer any clinically suitable patient onto eRD if they have already agreed to receive electronic prescriptions by nominating a pharmacy, or where the practice can issue non-nominated EPS prescriptions. Patients are being contacted to inform them of the change.
Notes for Editors
- In EPS, patients can choose or ‘nominate’ a community pharmacy, distance selling/online pharmacy and/or Dispensing Appliance Contractor (DAC). Their prescriptions will then be sent electronically to their ‘nominated’ dispenser.
- More information about EPS is available here
- Statistics on the usage of EPS are available here
Latest News from
New statistics released on talking therapies in England31/07/2020 09:15:00
New annual figures have been released by NHS Digital on referrals to talking therapies in England during 2019-20.
NHS Digital director nominated for British Ex-Forces In Business Award28/07/2020 11:15:00
Ian Phoenix, NHS Digital’s Director of Citizen Health Technology, has been nominated for a British Ex-Forces In Business Lifetime Achievement Award.
Annual statistical report into Female Genital Mutilation (FGM) published23/07/2020 11:15:00
NHS Digital has today published the Female Genital Mutilation (FGM) Enhanced Dataset annual report 2019/20.
New information shows healthcare activity and outcomes for the shielded population22/07/2020 09:15:00
A new aggregate data set that provides information on healthcare activity and outcomes of shielded patients was yesterday published by NHS Digital.
Coronavirus test results now visible to GPs21/07/2020 09:15:00
COVID-19 test results are now being automatically sent to GP systems as well as being communicated to the individual, giving GPs visibility of which of their patients have had COVID-19 tests and whether they have tested positive or negative.
New service enables people to sign up to be contacted for COVID-19 vaccine studies20/07/2020 16:15:00
A new NHS service has been launched today (20 July) to enable people across the UK to sign up for information on COVID-19 vaccine trials.
Data collection from adult social care will aid research into coronavirus trends in care settings16/07/2020 09:15:00
The Social Care Data Collection for Pandemic Planning and Research will collect existing, anonymised data on the COVID-19 status of care givers and care receivers directly from IT systems.
NHS Digital supports cardiovascular hospital admission research published yesterday in the Lancet15/07/2020 14:15:00
New data from NHS Digital has been used by the University of Oxford for a study looking at the weekly cardiac-related hospital admissions during the COVID-19 pandemic.
Regional coronavirus cases and triage figures published in new interactive dashboard06/07/2020 09:20:00
NHS Digital has published an interactive dashboard showing the number of coronavirus cases identified through Pillar 1 and 2 testing and the total number of NHS Pathways triages through 111 and 999, and online assessments in 111 Online which received a potential COVID-19 final disposition.